Crescent Biopharma, Inc. (CBIO) Earnings History

Quarterly EPS Results — source: SEC EDGAR

Quarter	EPS Estimate	EPS Actual	Surprise	Result
Q22026 FY2026	$-0.78	—	—	Miss

Back to CBIO overview · CBIO holders · CBIO KPIs

Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.